Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endotoxin Challenge with CCRE Lot 94332B1 in Healthy Volunteers
NCT02789241Phase 1Completed
- Start
- Aug 2016
- Primary completion
- Oct 2016
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lipopolysaccharide endotoxin in sepsis (5 arms). Primary endpoints: Change in heart rate, Number of treatment emergent adverse events and 6 more. Started Aug 2016; status: completed.
02
Drugs
lipopolysaccharide endotoxin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT02789241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02789241.